Publication | Open Access

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Ps 2OncologyMedicineSingle-agent GemcitabineMetronomic TherapyPharmacotherapyCancer TreatmentPharmacologyCancer ChemotherapyLung Cancer